Compare FTH & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FTH | RERE |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 835.7M | 832.8M |
| IPO Year | 2021 | 2021 |
| Metric | FTH | RERE |
|---|---|---|
| Price | $19.61 | $3.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 4 |
| Target Price | ★ $56.14 | $6.62 |
| AVG Volume (30 Days) | 331.0K | ★ 472.6K |
| Earning Date | 11-13-2026 | 11-19-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $27.40 |
| Revenue Next Year | N/A | $21.96 |
| P/E Ratio | ★ N/A | $34.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.50 | $3.50 |
| 52 Week High | $42.14 | $6.47 |
| Indicator | FTH | RERE |
|---|---|---|
| Relative Strength Index (RSI) | 29.10 | 51.61 |
| Support Level | N/A | $3.81 |
| Resistance Level | $36.63 | $4.10 |
| Average True Range (ATR) | 2.32 | 0.11 |
| MACD | -0.72 | 0.03 |
| Stochastic Oscillator | 11.64 | 64.77 |
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platforms PJT Marketplace and Paipai Marketplace. The Company's principal operations and geographic markets are in the People's Republic of China.